AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2022
Feb 3, 2022
29745_dirs_2022-02-03_d43268b3-0a4e-4f07-9371-d1fcc6c37be0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2022-02-01
Reporting Person: Pusey Leigh Ann (SVP, Corp. Affairs & Comm.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-01 | Common Stock | M | 4416 | — | Acquired | 22945 | Direct |
| 2022-02-01 | Common Stock | F | 2010 | $245.39 | Disposed | 20935 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-01 | Restricted Stock Unit | $ | M | 4416 | Disposed | 2022-02-01 | Common Stock (4416.0) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29